Naomi Eichenbaum | VP, IR |
Eric Dube | President, CEO and Director |
Jula Inrig | Chief Medical Officer |
Christopher Cline | CFO |
Peter Heerma | Chief Commercial Officer |
William Rote | SVP, Research and Development |
Maury Raycroft | Jefferies |
Greg Harrison | Bank of America |
Joseph Schwartz | SVB Securities |
Leon Wang | Barclays |
Liisa Bayko | Evercore ISI |
Laura Chico | Wedbush Securities |
Vamil Divan | Guggenheim Securities |
Alex Thompson | Stifel |
Ed Arce | HC Wainwright |
Good day, and welcome to the Travere Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference call over to Vice President of Investor Relations, Naomi Eichenbaum. Please go ahead, Naomi.
Thank you.